Literature DB >> 25194612

Tea consumption and lung cancer risk: a meta-analysis of case-control and cohort studies.

Lanfang Wang1, Xingwei Zhang2, Jing Liu2, Li Shen3, Zhiqiang Li4.   

Abstract

OBJECTIVE: Recent epidemiologic studies, especially cohort and case-control studies, have yielded inconsistent findings regarding the association between tea consumption and risk for lung cancer. The aim of this study was to assess a potential relationship between tea consumption and the incidence of lung cancer worldwide.
METHODS: A systematic literature search of PubMed, Web of Science, the Cochrane Library, Google Scholar, the Chinese Biomedical Database, and Wanfang Database was conducted from 1966 to January 2014 by two investigators. All cohort studies and case-control studies that evaluated the association of tea and lung cancer were included. Summary relative risks (RR) and the corresponding 95% confidence intervals (CIs) were calculated using a random-effects model. Quality assessments were performed using the Newcastle-Ottawa Scale. Heterogeneity was assessed using the Q and I(2) tests, and the source of heterogeneity was detected by meta-regression analysis. Publication bias was evaluated with Egger's regression symmetry test. Subgroup analyses and sensitivity analysis were performed.
RESULTS: Thirty-eight lung cancer studies (26 case-control studies and 12 cohort studies) with 59,041 cases and 396,664 controls were included. Overall tea consumption was significantly associated with decreased risk for lung cancer (RR, 0.78; 95% CI, 0.70-0.87). Subgroup analyses showed that tea consumption was associated with reduced risk for lung cancer in women (RR, 0.76; 95% CI, 0.62-0.93), case-control studies (RR 0.72; 95% CI 0.63-0.83), Western studies (RR, 0.85; 95% CI, 0.75-0.97), and studies in China and Japan (RR, 0.74; 95% CI, 0.62-0.88). Both green tea (RR, 0.75; 95% CI, 0.62-0.91) and black tea (RR, 0.82; 95% CI, 0.71-0.94) were significantly associated with reduced lung cancer risk. No significant association was found in men or in cohort studies.
CONCLUSION: Tea consumption may offer some protection against lung cancer.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lung cancer; Meta-analysis; Tea

Mesh:

Substances:

Year:  2014        PMID: 25194612     DOI: 10.1016/j.nut.2014.02.023

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  10 in total

Review 1.  Green tea and cancer and cardiometabolic diseases: a review of the current epidemiological evidence.

Authors:  Sarah Krull Abe; Manami Inoue
Journal:  Eur J Clin Nutr       Date:  2020-08-20       Impact factor: 4.016

Review 2.  Nature, Nurture, and Cancer Risks: Genetic and Nutritional Contributions to Cancer.

Authors:  Evropi Theodoratou; Maria Timofeeva; Xue Li; Xiangrui Meng; John P A Ioannidis
Journal:  Annu Rev Nutr       Date:  2017-08-21       Impact factor: 11.848

3.  Associations between tea and coffee beverage consumption and the risk of lung cancer in the Singaporean Chinese population.

Authors:  Wei Jie Seow; Woon-Puay Koh; Aizhen Jin; Renwei Wang; Jian-Min Yuan
Journal:  Eur J Nutr       Date:  2019-12-10       Impact factor: 5.614

4.  Associations of coffee and tea consumption with lung cancer risk.

Authors:  Jingjing Zhu; Stephanie A Smith-Warner; Danxia Yu; Xuehong Zhang; William J Blot; Yong-Bing Xiang; Rashmi Sinha; Yikyung Park; Shoichiro Tsugane; Emily White; Woon-Puay Koh; Sue K Park; Norie Sawada; Seiki Kanemura; Yumi Sugawara; Ichiro Tsuji; Kim Robien; Yasutake Tomata; Keun-Young Yoo; Jeongseon Kim; Jian-Min Yuan; Yu-Tang Gao; Nathaniel Rothman; DeAnn Lazovich; Sarah K Abe; Md Shafiur Rahman; Erikka Loftfield; Yumie Takata; Xin Li; Jung Eun Lee; Eiko Saito; Neal D Freedman; Manami Inoue; Qing Lan; Walter C Willett; Wei Zheng; Xiao-Ou Shu
Journal:  Int J Cancer       Date:  2020-12-16       Impact factor: 7.316

Review 5.  Anticancer Properties of Phyllanthus emblica (Indian Gooseberry).

Authors:  Tiejun Zhao; Qiang Sun; Maud Marques; Michael Witcher
Journal:  Oxid Med Cell Longev       Date:  2015-06-09       Impact factor: 6.543

6.  An inverse association between tea consumption and colorectal cancer risk.

Authors:  Yuetong Chen; Yuan Wu; Mulong Du; Haiyan Chu; Lingjun Zhu; Na Tong; Zhengdong Zhang; Meilin Wang; Dongying Gu; Jinfei Chen
Journal:  Oncotarget       Date:  2017-06-06

7.  Antimutagenic and anticlastogenic effects of Turkish Black Tea on TA98 and TA100 strains of Salmonella typhimurium (in vitro) and mice (in vivo).

Authors:  Mohammad Charehsaz; Hande Sipahi; Ashok Kumar Giri; Ahmet Aydin
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

8.  Coffee and Tea Consumption and the Contribution of Their Added Ingredients to Total Energy and Nutrient Intakes in 10 European Countries: Benchmark Data from the Late 1990s.

Authors:  Edwige Landais; Aurélie Moskal; Amy Mullee; Geneviève Nicolas; Marc J Gunter; Inge Huybrechts; Kim Overvad; Nina Roswall; Aurélie Affret; Guy Fagherazzi; Yahya Mahamat-Saleh; Verena Katzke; Tilman Kühn; Carlo La Vecchia; Antonia Trichopoulou; Elissavet Valanou; Calogero Saieva; Maria Santucci de Magistris; Sabina Sieri; Tonje Braaten; Guri Skeie; Elisabete Weiderpass; Eva Ardanaz; Maria-Dolores Chirlaque; Jose Ramon Garcia; Paula Jakszyn; Miguel Rodríguez-Barranco; Louise Brunkwall; Ena Huseinovic; Lena Nilsson; Peter Wallström; Bas Bueno-de-Mesquita; Petra H Peeters; Dagfinn Aune; Tim Key; Marleen Lentjes; Elio Riboli; Nadia Slimani; Heinz Freisling
Journal:  Nutrients       Date:  2018-06-05       Impact factor: 5.717

Review 9.  Association of Lung Cancer and Tea-Drinking Habits of Different Subgroup Populations: Meta-Analysis of Case-Control Studies and Cohort Studies.

Authors:  Zijun Guo; Mei Jiang; Wenting Luo; Peiyan Zheng; Huimin Huang; Baoqing Sun
Journal:  Iran J Public Health       Date:  2019-09       Impact factor: 1.429

10.  Green tea (Camellia sinensis) for the prevention of cancer.

Authors:  Tommaso Filippini; Marcella Malavolti; Francesca Borrelli; Angelo A Izzo; Susan J Fairweather-Tait; Markus Horneber; Marco Vinceti
Journal:  Cochrane Database Syst Rev       Date:  2020-03-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.